Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions.

Saved in:
Bibliographic Details
Title: Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions.
Authors: Tian DD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Hall SD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Chapman SC; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Posada MM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2025 Dec; Vol. 14 (12), pp. 2221-2231. Date of Electronic Publication: 2025 Oct 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2163-8306
DOI:10.1002/psp4.70134